Amphion Innovations plc
Change of Adviser

London and New York, 28 March 2013 - Amphion Innovations plc (AIM: AMP), the developer of medical and technology businesses, is pleased to announce the appointment of Panmure Gordon (UK) Limited as its nominated adviser and broker with immediate effect. 

For further information please contact

Amphion Innovations plc
Charlie Morgan
+1 212 210 6224

Novella Communications
Tim Robertson
+44 (0)7900 927 650

Panmure Gordon Limited
Freddy Crossley / Grishma Patel (Corporate Finance)
Adam Pollock / Victoria Boxall (Corporate Broking)
+44 020 7886 2500


About Amphion Innovations plc
Amphion (LSE: AMP) builds shareholder value in emerging companies in the medical and technology sectors, by using a focused, hands-on company building approach, based on decades of experience in both the US and UK. Amphion has significant shareholding in 7 Partner Companies developing proven technologies targeting substantial commercial marketplaces. The Amphion model has been refined to optimise the commercialisation of patents and other intellectual property within the Partner Companies. The Partner Companies collectively own or control over 200 separately identified pieces of intellectual property, a number which grows rapidly each year.

On the web: